Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Finch Therapeutics
Biotech
BMS CEO set to leave after 8-year run—Chutes & Ladders
BMS CEO retiring. AbbVie plots CEO succession. Ipsen taps new CMO.
Max Bayer
,
Gabrielle Masson
Apr 28, 2023 9:30am
Finch continues to pinch pennies to stretch cash into 2025
Mar 24, 2023 11:10am
Finch stops phase 3, lays off 95% of staff and plans asset sale
Jan 24, 2023 10:00am
Finch axes 37% of staff days after Takeda returns unhatched meds
Sep 1, 2022 11:28am
Takeda returns 2 IBD prospects back to Finch's nest
Aug 26, 2022 11:01am
Top 10 game-changing biotech layoffs in H1
Jul 19, 2022 3:00am
